JANX - Janux Therapeutics Inc
IEX Last Trade
47.03
2.390 5.082%
Share volume: 423,888
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$44.64
2.39
5.35%
Summary score
8%
Profitability
0%
Dept financing
3%
Liquidity
75%
Performance
1%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.34%
Return on assets
-4.56%
Return on sales
-1007.29%
Return on invested capital
-65.88%
Total debt ratio
9.56%
Debt ratio change over timeo
-1.08%
Current Ratio
27.62%
Quick Ratio
27.62%
Cash Position Ratio
27.25%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.71%
Return on assets
-4.33%
Return on sales
-1214.29%
Return on invested capital
-82.38%
Total debt ratio
9.1%
Debt ratio change over timeo
-1.07%
Current Ratio
32.68%
Quick Ratio
32.68%
Cash Position Ratio
32.23%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-2.25%
Return on assets
-2.93%
Return on sales
-1610.3%
Return on invested capital
-74.89%
Total debt ratio
4.82%
Debt ratio change over time
-1.07%
Current Ratio
62.09%
Quick Ratio
62.09%
Cash Position Ratio
61.43%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-96.5%
Return on assets
-96.21%
Return on sales
676.03%
Return on invested capital
-45.53%
Total debt ratio
-108.11%
Debt ratio change over time
-1.08%
Current Ratio
-30.31%
Quick Ratio
-30.31%
Cash Position Ratio
-29.95%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | JANX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.34% | 13.79% | 34.47% | 7.43% |
| Return on assets | -4.56% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1007.29% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -65.88% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 9.56% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.08% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 32.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 32.68% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 32.23% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 2% | 4% | 9% |
| Short-term ratios | JANX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -3.71% | 13.77% | 13.25% | 3.8% |
| Return on assets | -4.33% | 2.43% | 1.89% | 3.09% |
| Return on sales | -1214.29% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -82.38% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 9.1% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.07% | 46.38% | -72.08% | 1.51% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 32.68% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 32.68% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 32.23% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 2% | 4% | 10% |